当前位置:首页 > 化工头条

UK opens anti-dumping probe into US LLDPE imports after Ineos complaint

化工头条2026-07-066
B910化工消息:July 3 - The UK Trade Remedies Authority (TRA) has officially launched an anti-dumping investigation into linear low-density polyethylene (LLDPE) imports from the United States, initiated following a complaint by UK domestic producer Ineos. Ineos alleged in its complaint that US LLDPE is entering the UK market at prices below normal value, causing material injury to domestic producers. The TRA investigation will assess whether US LLDPE is being dumped and whether such dumping is causing or threatening material injury to the UK domestic industry. The background to this anti-dumping investigation is profound changes in global polyethylene capacity patterns. Benefiting from low-cost ethane feedstock brought by the shale gas revolution, the United States has massively expanded polyethylene capacity over the past decade, with significant LLDPE exports flowing to European and UK markets. As the UK independent trade policy framework post-Brexit gradually takes shape, UK domestic chemical companies are beginning to use anti-dumping tools to protect domestic industry. Market analysts noted that if the UK ultimately imposes anti-dumping duties on US LLDPE, some US exports originally destined for the UK may redirect to the EU market, exacerbating LLDPE oversupply pressure in the EU region. The current European polyethylene market already faces dual pressures of weak demand and import competition, and additional supply inflows could further depress prices and margins. Furthermore, this investigation also reflects the continuation of global chemical trade protectionism trends. As major economies including the US and EU strengthen trade remedy measures, the UK as an independent trade policy entity is also actively utilizing related tools. For Ineos, successfully obtaining anti-dumping duty protection would help maintain reasonable operating rates and profitability at its UK LLDPE facilities. The investigation is expected to last several months, during which interested parties can submit evidence and opinions. (来源:Plasteurope)

扫描二维码推送至手机访问。

版权声明:本文由B910化工发布,如需转载请注明出处。

本文链接:https://www.b910.cn/N/1728.html

标签: Array
分享给朋友:

相关文章

以色列空袭伊朗马赫沙尔石化综合体,停火后最大规模交火威胁地区重返全面战争

6月7日至8日,以色列空军对伊朗胡泽斯坦省马赫沙尔石化综合体实施精确打击,伊朗随即向以色列发射两轮弹道导弹进行报复。这是4月8日停火协议以来最严重的交火升级,正值伊朗战争爆发第100天。霍尔木兹海峡持…

LG化学开发100%可降解生物材料

近日,LG化学宣布,公司成功地开发出一种可生物降解的新材料。公司利用玉米成分的葡萄糖和废甘油,首次开发出100%可降解的生物材料。这种材料具有聚丙烯(PP)等合成树脂那样的机械强度和透明度,可替代相关…

宝洁警告2027财年利润将因油价上涨损失10亿美元,中东战争推高石化原料成本

宝洁公司4月24日发出盈利预警,预计2027财年因中东战争引发的油价飙升将损失约10亿美元利润。伊朗战争导致霍尔木兹海峡中断,推动原油价格大幅上涨,直接推高了这家全球最大消费品企业从包装到运输的全链条…

中国化学中标河南金马中东能源有限公司180万吨/年焦化项目安装工程

11月3日,中国化学九公司成功中标河南金马中东能源有限公司180万吨/年焦化项目安装工程。该项目位于河南金马中东能源有限公司现有厂区内,具体包括项目粗苯、油库、硫铵、脱硫、冷鼓、循环水等工段工艺管道、…

Ionis的Tryngolza获FDA扩大批准,用于重度高甘油三酯血症

BioPharma Dive报道,Ionis的RNA靶向药Tryngolza获FDA扩大批准,用于成人重度高甘油三酯血症,可作为饮食控制辅助疗法降低甘油三酯和急性胰腺炎风险。该药2025年净销售额为1…

罗氏双靶点肠促胰岛素acmopatide在1型糖尿病二期临床中展现疗效:A1C降低0.34%,胰岛素用量减少15%

罗氏在ADA 2026大会上公布acmopatide(CT-868,GLP-1/GIP双重激动剂)治疗肥胖型1型糖尿病的二期临床试验结果:糖化血红蛋白A1C降低0.34%,胰岛素用量减少约15%。这是…